NGAL Recombinant Protein
Target/reference protein material for calibration, control concepts, antibody characterization and analytical evaluation in NGAL-related assay development. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury.
Product Type
Antibodies & Antigens
Sub-Category
Functional & Reference Proteins
Platform
CLIA, TIA
Application
REN
Overview
Target/reference protein material for calibration, control concepts, antibody characterization and analytical evaluation in NGAL-related assay development. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury.
Target/reference protein material for calibration, control concepts, antibody characterization and analytical evaluation in NGAL-related assay development. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury. NGAL can rise early in plasma or urine after kidney injury and has been extensively studied as an AKI biomarker. Reference populations and decision values remain method and context dependent.
Professional Context
NGAL can rise early in plasma or urine after kidney injury and has been extensively studied as an AKI biomarker. Reference populations and decision values remain method and context dependent.
Technical Specifications
Antibody Information
| Parameter | Specification |
|---|---|
| Target | NGAL |
| Technology Platform | Chemiluminescence |
| Application Tags | REN |
| Storage | -25~ -10℃ |
| Shelf Life | 2年 |
| Sample Pack | 0.2mg |
Target
NGAL
Technology Platform
Chemiluminescence
Application Tags
REN
Storage
-25~ -10℃
Shelf Life
2年
Sample Pack
0.2mg
Technical Resources
Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.
Need to confirm the right product or material for your project?
Our technical team can assist with product selection, provide samples, and support your IVD development project.





